Novus Biologicals products are now on bio-techne.com

ErbB2/Her2

Unlocking the Potential of Biosimilars in Immuno-Oncology

By Jennifer Jones, M.S.

Read more about Unlocking the Potential of Biosimilars in Immuno-Oncology
Log in or register to post comments

NPC1: A Potential Target For Triple-Negative Breast Cancer

By Natalia Gurule, PhD

Tags:

Triple-Negative Breast Cancer

Niemann-Pick C1

Read more about NPC1: A Potential Target For Triple-Negative Breast Cancer
Log in or register to post comments

Hypoxia-Dependent CAR Stabilizing Construct in T cells Improves Solid Tumor Targeting and Efficacy

By Victoria Osinski, PhD

Tags:

Chimeric Antigen Receptor

Tumor Microenvironment

Victoria Osinski

Read more about Hypoxia-Dependent CAR Stabilizing Construct in T cells Improves Solid Tumor Targeting and Efficacy
Log in or register to post comments

Harnessing Natural Killer Cell Activity for Anti-Tumor Immunotherapy

By Victoria Osinski, PhD

Read more about Harnessing Natural Killer Cell Activity for Anti-Tumor Immunotherapy
Log in or register to post comments

Targeting Success in CAR-T Therapy for Solid Tumors

By Jacqueline Carrico, BS, MD Candidate

Tags:

IL-13 R alpha 2

Read more about Targeting Success in CAR-T Therapy for Solid Tumors
Log in or register to post comments

Popular Products	Company Information	Support	Stay Connected
Antibodies Secondary Antibodies Isotype Controls Proteins and Peptides ELISA Kits Sample Size New Products	About Us Careers Novus Guarantee Contact Us Our Team	Technical Support FAQs Help Finding Antibodies Protocols

Visit our other sites

©2024 Novus Biologicals, All Rights Reserved.